文献速递腹部外周血管介入US

肝移植术后早期多普勒超声使用硝苯地平预测短期并发症与长期结局的价值

Utility of nifedipine use for Doppler ultrasound early after liver transplantation to predict short-term complications and long-term outcomes.
PubMed 文献 · Abdom Radiol (NY) · 2024-01-14

回顾性单中心研究纳入2005年1月1日至2015年12月31日肝移植术后3天内行多普勒超声的444例患者,比较使用与未使用硝苯地平组及硝苯地平反应组与无反应组的再移植、再手术、经皮介入和总生存率。硝苯地平反应组再手术率低于对照组(15.9% vs 24.1%,p=0.03)和无反应组(15.9% vs 31.8%,p=0.004),1年和2年总生存率组间相似(所有p值>0.37)。

要点

  • 硝苯地平反应组再手术率15.9%,低于对照组24.1%(p=0.03)和无反应组31.8%(p=0.004)。
  • 硝苯地平使用组与对照组再移植率和经皮介入率无差异(所有p值分别≥0.2和≥0.08)。
  • 各组1年和2年总生存率相似(所有p值>0.37)。

核心结论

  • 肝移植术后多普勒超声对硝苯地平有反应的患者短期并发症率和长期结局与无需使用硝苯地平者相似,对硝苯地平无反应与更高的再手术率相关。

研究设计与样本

  • 回顾性单中心研究,纳入2005年1月1日至2015年12月31日肝移植术后3天内行多普勒超声的患者444例(男305例/女139例,平均年龄51.7±17.4岁,肝移植至多普勒超声平均间隔1.12±0.9天),硝苯地平研究组220例(反应者157/220,71.4%;无反应者63/220,28.6%),对照组224例。

诊断标准与关键数值

  • 硝苯地平阳性反应定义为给药后初始无肝动脉血流者出现肝动脉血流或肝动脉阻力指数(RI)降低≥0.1。

临床应用与阅片要点

  • 肝移植术后早期多普勒超声可评估肝动脉血流并对硝苯地平给药反应进行观察。
  • 硝苯地平反应者再手术率较低,无反应者再手术率较高。
  • 硝苯地平使用组与对照组再移植率、经皮介入率和1年、2年总生存率无显著差异。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To evaluate the response to nifedipine administration measured by changes in hepatic arterial (HA) flow on post-operative Doppler ultrasound (US) to predict short-term complications and long-term outcomes in liver transplant (LT) patients.

METHODS: Patients who underwent LT with post-operative Doppler US within 3 days between 1 January 2005 and 31 December 2015 were included in this retrospective single center study. The patients who received and did not receive nifedipine during the Doppler US comprised the study and control groups, respectively. A positive response to nifedipine was defined as the detection of HA flow when none was present initially or a reduction in HA resistive index (RI) ≥ 0.1 after nifedipine administration. The rates of re-transplantation, re-operation, percutaneous intervention (PCI), and overall survival (OS) were recorded. Cox proportional hazards regression was used to evaluate the association of clinic-demographic variables and Doppler findings with the outcome measures.

RESULTS: 444 LT patients (305 M/139F, mean age 51.7 ± 17.4 years, mean interval between LT-Doppler US 1.12 ± 0.9 days) are presented. 220 patients comprised the nifedipine study group [n = 157/220 (71.4%) responder, n = 63/220 (28.6%) nonresponder] and 224 patients comprised the control group. There was no difference in re-transplantation or PCI rates between the groups (all p-values ≥ 0.2 and ≥ 0.08, respectively). The responder group had a lower rate of re-operation vs. the control group (15.9% vs. 24.1%, p = 0.03) and nonresponder group (15.9% vs. 31.8%, p = 0.004). 1-year and 2-year OS were similar between the groups (all p-values > 0.37).

CONCLUSION: Short-term complication rates and long-term outcomes for patients with liver transplant who responded to nifedipine administration on Doppler US are similar to those who did not require nifedipine administration. A lack of response to nifedipine was associated with a higher re-operation rate.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Kadaba P, Beitia L, Rosen A, et al. Utility of nifedipine use for Doppler ultrasound early after liver transplantation to predict short-term complications and long-term outcomes. Abdom Radiol (NY). 2024. PMID: 38219253. doi:10.1007/s00261-023-04152-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。